Azathioprine (AZA) is approved by the Food and Drug Administration (FDA) for the symptomatic treatment of active rheumatoid arthritis. It also has approval as adjunctive therapy for the prevention of kidney transplant rejection.

AZA used off-label for the treatment of inflammatory bowel disease,